Search filters

List of works by Dorota Dybowska

Acute hepatic failure in the course of alcohol-paracetamol syndrome--case report.

scientific article

Agranulocytosis during treatment of chronic hepatitis C complicated by hyperthyreosis. Case reports

scientific article published on January 1, 2012

Anthrax as a pathogen for a biological weapon

scientific article published in February 2003

Association of IL28B Polymorphisms With the Response to Peginterferon Plus Ribavirin Combined Therapy in Polish Patients Infected With HCV Genotype 1 and 4.

scientific article

Budd-Chiari syndrome--from diagnosis to treatment--case reports

scientific article published in March 2008

Can pegylated interferon α 2a cause development of thyroid disorders in patients with chronic hepatitis B?

scientific article published on 14 June 2014

Changes in patient profile, treatment effectiveness, and safety during 4 years of access to interferon-free therapy for hepatitis C virus infection

scientific article published on 07 February 2020

Comparative effectiveness of 8 versus 12 weeks of Ombitasvir/Paritaprevir/ritonavir and Dasabuvir in treatment-naïve patients infected with HCV genotype 1b with non-advanced hepatic fibrosis

scientific article published on 13 December 2019

Effectiveness and Safety of Pangenotypic Regimens in the Most Difficult to Treat Population of Genotype 3 HCV Infected Cirrhotics

scientific article

Efficacy of triple therapy in patients with chronic hepatitis C not treated and patients previously treated ineffectively

scientific article published on January 1, 2012

Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study

scientific article published on 01 May 2021

HCV Genotype Has No Influence on the Incidence of Diabetes—EpiTer Multicentre Study

scientific article published on 13 January 2022

Hepatitis C Infection as a Risk Factor for Hypertension and Cardiovascular Diseases: An EpiTer Multicenter Study

scientific article published in September 2022

Is Interferon-Based Treatment of Viral Hepatitis C Genotype 3 Infection Still of Value in the Era of Direct-Acting Antivirals?

scientific article published in February 2018

Is an 8-week regimen of glecaprevir/pibrentasvir sufficient for all HCV infected patients in the real-world experience?

scientific article published on 10 November 2020

Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA

scientific article published on 13 June 2020

Monoexponential and Biexponential Fitting of Diffusional Magnetic Resonance Imaging Signal Analysis for Prediction of Liver Fibrosis Severity

scientific article published on 01 November 2019

Neuropsychiatric adverse events in patients with chronic hepatitis C treated with pegylated or recombinant interferon-alpha

scientific article published in January 2008

Preparation of HCV infected patients to the triple therapy with first generation protease inhibitors

scientific article published on January 2013

Real World Experience of Chronic Hepatitis C Retreatment with Genotype Specific Regimens in Nonresponders to Previous Interferon-Free Therapy

scientific article published on 03 March 2019

Real-world experience with Grazoprevir/Elbasvir in the treatment of previously "difficult to treat" patients infected with hepatitis C virus genotype 1 and 4.

scientific article

Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitors

scientific article published on 29 October 2015

The Impact of IL28B Genotype and Liver Fibrosis on the Hepatic Expression of IP10, IFI27, ISG15, and MX1 and Their Association with Treatment Outcomes in Patients with Chronic Hepatitis C.

scientific article published on 26 June 2015

The efficacy of paritaprevir/ritonavir/ombitasvir+dasabuvir and ledipasvir/sofosbuvir is comparable in patients who failed interferon-based treatment with first generation protease inhibitors - a multicenter cohort study

scholarly article by Ewa Janczewska et al published 16 November 2018 in BMC Infectious Diseases

Treatment with natural interferon (alfaferone) in clinical practice--our experience

scientific article

[Borreliosis--increasing clinical problem]

scientific article published on 01 January 2006

[Forecasting of efficacy of chronic hepatitis B therapy]

scientific article published on 01 January 2012

[Prevalence of borreliosis among forestry workers in Kujawsko-Pomorskie voivodeship]

scientific article published on 01 January 2007

[Treatment of chronic hepatitis B]

scientific article published on 01 January 2004

Paulina is supported by:

About Paulina

Help